Novel Biomarkers Predict Heart, Kidney Disease in People with T2D
American Heart Association
The CREDENCE trial demonstrated how canagliflozin treatment brought down the levels of cardiorenal blood biomarkers
Articles by American Heart Association
“One-Size-Fits-All” Flawed for Assessing Cardiovascular Disease Risk
American Heart Association
Study examines death rates for cardiovascular diseases in various Asian ethnicity subgroups
New Statement Highlights Need to Reduce “Low-Value” Heart Care
American Heart Association
Half of US patients receive one low-value test or procedure annually
Heart Failure Diagnoses May Be Missed in a Primary Care Setting
American Heart Association
Many heart failure diagnoses may be missed in a primary care setting, particularly among women and Black adults